228 related articles for article (PubMed ID: 27322569)
21. Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning.
Zhang Y; Gu EW; Zhang J; Chen ZW
Chin Med J (Engl); 2007 May; 120(9):777-81. PubMed ID: 17531118
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.
Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA
J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
24. [D-Ala2,D-Leu5]-enkephalin (DADLE) and morphine-induced postconditioning by inhibition of mitochondrial permeability transition pore, in human myocardium.
Fuardo M; Lemoine S; Lo Coco C; Hanouz JL; Massetti M
Exp Biol Med (Maywood); 2013 Apr; 238(4):426-32. PubMed ID: 23436882
[TBL] [Abstract][Full Text] [Related]
25. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts.
Chen HT; Yang CX; Li H; Zhang CJ; Wen XJ; Zhou J; Fan YL; Huang T; Zeng YM
Acta Pharmacol Sin; 2008 Aug; 29(8):931-41. PubMed ID: 18664326
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of reactive oxygen species downregulates the MAPK pathway in rat spinal cord after limb ischemia reperfusion injury.
Choi EK; Yeo JS; Park CY; Na Hi; Lim Ja; Lee JE; Hong SW; Park SS; Lim DG; Kwak KH
Int J Surg; 2015 Oct; 22():74-8. PubMed ID: 26283297
[TBL] [Abstract][Full Text] [Related]
27. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury.
Yu D; Li M; Tian Y; Liu J; Shang J
Life Sci; 2015 Feb; 122():15-25. PubMed ID: 25476833
[TBL] [Abstract][Full Text] [Related]
28. Edaravone inhibits JNK-c-Jun pathway and restores anti-oxidative defense after ischemia-reperfusion injury in aged rats.
Wen J; Watanabe K; Ma M; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
Biol Pharm Bull; 2006 Apr; 29(4):713-8. PubMed ID: 16595905
[TBL] [Abstract][Full Text] [Related]
29. Midazolam suppresses ischemia/reperfusion-induced cardiomyocyte apoptosis by inhibiting the JNK/p38 MAPK signaling pathway.
Zhou W; Cai D
Can J Physiol Pharmacol; 2022 Feb; 100(2):117-124. PubMed ID: 34559975
[TBL] [Abstract][Full Text] [Related]
30. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV
Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial permeability transition pore plays a role in the cardioprotection of CB2 receptor against ischemia-reperfusion injury.
Li Q; Guo HC; Maslov LN; Qiao XW; Zhou JJ; Zhang Y
Can J Physiol Pharmacol; 2014 Mar; 92(3):205-14. PubMed ID: 24593785
[TBL] [Abstract][Full Text] [Related]
32. Effect of c-Jun N-terminal kinase (JNK)/p38 mitogen-activated protein kinase (p38 MAPK) in morphine-induced tau protein hyperphosphorylation.
Cao M; Liu F; Ji F; Liang J; Liu L; Wu Q; Wang T
Behav Brain Res; 2013 Jan; 237():249-55. PubMed ID: 23026374
[TBL] [Abstract][Full Text] [Related]
33. Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection.
Peart JN; Gross ER; Headrick JP; Gross GJ
J Mol Cell Cardiol; 2007 May; 42(5):972-80. PubMed ID: 17407780
[TBL] [Abstract][Full Text] [Related]
34. p38-MAPK and PKB/Akt, possible role players in red palm oil-induced protection of the isolated perfused rat heart?
Engelbrecht AM; Esterhuyse J; du Toit EF; Lochner A; van Rooyen J
J Nutr Biochem; 2006 Apr; 17(4):265-71. PubMed ID: 16229999
[TBL] [Abstract][Full Text] [Related]
35. Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism.
Ge ZD; Pravdic D; Bienengraeber M; Pratt PF; Auchampach JA; Gross GJ; Kersten JR; Warltier DC
Anesthesiology; 2010 Jan; 112(1):73-85. PubMed ID: 19996950
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of sauchinone against regional myocardial ischemia/reperfusion injury: inhibition of p38 MAPK and JNK death signaling pathways.
Kim SJ; Jeong CW; Bae HB; Kwak SH; Son JK; Seo CS; Lee HJ; Lee J; Yoo KY
J Korean Med Sci; 2012 May; 27(5):572-5. PubMed ID: 22563228
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury.
Kumphune S; Surinkaew S; Chattipakorn SC; Chattipakorn N
Pharm Biol; 2015; 53(12):1831-41. PubMed ID: 25880145
[TBL] [Abstract][Full Text] [Related]
38. Comparison of cardio-protective effects induced by different modalities of sevoflurane conditioning in isolated rat hearts.
Yao YT; Liu DH; Li LH
Perfusion; 2016 Mar; 31(2):156-63. PubMed ID: 26060199
[TBL] [Abstract][Full Text] [Related]
39. Cryptotanshinone Ameliorates Hepatic Normothermic Ischemia and Reperfusion Injury in Rats by Anti-mitochondrial Apoptosis.
Sun PP; Yuan F; Xu J; Sai K; Chen J; Guan S
Biol Pharm Bull; 2014; 37(11):1758-65. PubMed ID: 25366482
[TBL] [Abstract][Full Text] [Related]
40. Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non-heart-beating donors.
Dong B; Stewart PW; Egan TM
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):429-36.e1. PubMed ID: 23260460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
